FUNCTIONAL ANALYSIS OF THE H3.3-K27M MUTATION IN DIPG

被引:0
|
作者
Rakopoulos, Patricia [1 ]
Pajovic, Sanja [3 ]
Buczkowicz, Pawel [1 ]
Morrison, Andrew [3 ]
Bouffet, Eric [3 ]
Bartels, Ute [3 ]
Becher, Oren [2 ]
Hawkins, Cynthia [3 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Duke Univ, Durham, NC USA
[3] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
0141
引用
收藏
页码:38 / 38
页数:1
相关论文
共 50 条
  • [31] The H3.3K27M oncohistone antagonizes reprogramming in Drosophila
    Ahmad, Kami
    Henikoff, Steven
    PLOS GENETICS, 2021, 17 (07):
  • [32] Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression
    Lopez, Giselle Y.
    Bush, Nancy Ann Oberheim
    Phillips, Joanna J.
    Bouffard, John-Paul
    Moshel, Yaron A.
    Jaeckle, Kurt
    Kleinschmidt-DeMasters, B. K.
    Rosenblum, Marc K.
    Perry, Arie
    Solomon, David A.
    ACTA NEUROPATHOLOGICA, 2017, 134 (06) : 961 - 963
  • [33] Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression
    Giselle Y. Lopez
    Nancy Ann Oberheim Bush
    Joanna J. Phillips
    John-Paul Bouffard
    Yaron A. Moshel
    Kurt Jaeckle
    B. K. Kleinschmidt-DeMasters
    Marc K. Rosenblum
    Arie Perry
    David A. Solomon
    Acta Neuropathologica, 2017, 134 : 961 - 963
  • [34] Clinical and immunohistochemical analysis of H3.3 K27M antibody positive glioma
    Yamasaki, Fumiyuki
    Takayasu, Takeshi
    Takano, Motoki
    Yonezawa, Ushio
    Amatya, Vishwa J.
    Yoshihiro, Masako
    Takeshima, Yukio
    Sugiyama, Kazuhiko
    Kurisu, Kaoru
    Karlowee, Vega
    BRAIN PATHOLOGY, 2019, 29 : 188 - 188
  • [35] Knock-down of H3.3 K27M mutant protein in DIPG cells delays, but does not abrogate, tumor growth in vivo
    Silveira, Andre B.
    Zhu, Xiaoyan
    Qu, Chunxu
    Baker, Suzanne
    CANCER RESEARCH, 2015, 75
  • [36] Engineered Exosomes with Ouabain for H3K27M-Mutated DIPG Therapy
    Shan, Shaobo
    Chen, Junge
    Qing, Guangchao
    Xie, Luyang
    Xia, Bozhang
    Pan, Changcun
    Xu, Cheng
    Fang, Hongjuan
    Wan, Yichen
    Yang, Yun
    Fan, Yubo
    Liang, Xing-Jie
    Zhang, Liwei
    ADVANCED FUNCTIONAL MATERIALS, 2025, 35 (03)
  • [37] TREATMENT OF A PEDIATRIC PATIENT WITH AN H3.3 K27M MUTANT DIPG WITH ONC201, A SELECTIVE DRD2 ANTAGONIST
    Suarez, Fernando
    Stafford, James M.
    Tarapore, Rohinton
    Oster, Wolfgang
    Allen, Joshua E.
    Chi, Andrew S.
    Gardner, Sharon
    NEURO-ONCOLOGY, 2018, 20 : 60 - 60
  • [38] H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines
    Rakotomalala, Andria
    Bailleul, Quentin
    Savary, Clara
    Arcicasa, Melanie
    Hamadou, Maud
    Huchede, Paul
    Hochart, Audrey
    Restouin, Audrey
    Castellano, Remy
    Collette, Yves
    Dieny, Emma
    Vincent, Audrey
    Angrand, Pierre-Olivier
    Le Bourhis, Xuefen
    Leblond, Pierre
    Furlan, Alessandro
    Castets, Marie
    Pasquier, Eddy
    Meignan, Samuel
    CANCERS, 2021, 13 (21)
  • [39] Engineering new cellular models to decipher H3.3K27M mutation role in DIPGs' resistance to therapies
    Rakotomalala, Andria
    Lewandowski, Paul
    Bailleul, Quentin
    Savary, Clara
    Arcicasa, Melanie
    Bal, Christine
    Hamadou, Maud
    Huchede, Paul
    Restouin, Audrey
    Castellano, Remy
    Collette, Yves
    Vincent, Audrey
    Angrand, Pierre-Olivier
    Adriaenssens, Eric
    Le Bourhis, Xuefen
    Leblond, Pierre
    Castets, Marie
    Pasquier, Eddy
    Furlan, Alessandro
    Meignan, Samuel
    CANCER RESEARCH, 2022, 82 (12)
  • [40] Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4
    Mo, Yan
    Duan, Shoufu
    Zhang, Xu
    Hua, Xu
    Zhou, Hui
    Wei, Hong-Jian
    Watanabe, Jun
    McQuillan, Nicholas
    Su, Zhenyi
    Gu, Wei
    Wu, Cheng-Chia
    Vakoc, Christopher R.
    Hashizume, Rintaro
    Chang, Kenneth
    Zhang, Zhiguo
    CANCER DISCOVERY, 2022, 12 (12) : 2906 - 2929